Researchers developed a system that quickly translates brain signals for handwriting into text. While preliminary, this technology could help people with spinal cord injuries and neurological disorders who have lost the ability to write and speak to communicate.
Researchers are now able to wirelessly record the directly measured brain activity of people living with Parkinson’s disease and to then use that information to adjust the stimulation delivered by an implanted device.
NIH-funded researchers have developed a new ultrasound technique to monitor the placenta for impaired fetal blood flow early in pregnancy.
An investigational gene therapy can safely restore the immune systems of infants and children who have a rare, life-threatening inherited immunodeficiency disorder.
NIAID has awarded $10 million in first-year funding to establish a clinical research network called Childhood Asthma in Urban Settings (CAUSE). This nationwide network will conduct observational studies and clinical trials tailored to improve asthma treatments and prevention approaches in children of low-income families.
A new NIA study suggests that short sleep duration during midlife could increase the risk of developing dementia later in life.
In two landmark studies, researchers have used cutting-edge genomic tools to investigate the potential health effects of exposure to ionizing radiation, a known carcinogen, from the 1986 accident at the Chernobyl nuclear power plant in northern Ukraine.
NIH researchers have identified and tested a drug combination that exploits a weakness in small cell lung cancer (SCLC).
NIH researchers recently found that SARS-CoV-2, the virus that causes Covid-19, can infect cells in the mouth.
An NIH research team developed a test to evaluate the expressive language skills of people with Down syndrome, a condition resulting from an extra copy or piece of chromosome 21.